The stock of P3 Health Partners Inc (PIII) has gone down by -7.78% for the week, with a 2.69% rise in the past month and a -17.64% drop in the past quarter. The volatility ratio for the week is 9.08%, and the volatility levels for the past 30 days are 8.51% for PIII. The simple moving average for the last 20 days is -7.16% for PIII stock, with a simple moving average of -39.14% for the last 200 days.
Is It Worth Investing in P3 Health Partners Inc (NASDAQ: PIII) Right Now?
Additionally, the 36-month beta value for PIII is 1.18. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PIII is 87.68M and currently, short sellers hold a 1.49% ratio of that float. The average trading volume of PIII on August 13, 2024 was 353.93K shares.
PIII) stock’s latest price update
The stock of P3 Health Partners Inc (NASDAQ: PIII) has decreased by -8.80 when compared to last closing price of 0.61. Despite this, the company has experienced a -7.78% fall in its stock price over the last five trading sessions. accesswire.com reported 2024-08-12 that NEW YORK, NY / ACCESSWIRE / August 12, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. (“PII” or the “Company”) (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
Analysts’ Opinion of PIII
BTIG Research, on the other hand, stated in their research note that they expect to see PIII reach a price target of $5. The rating they have provided for PIII stocks is “Buy” according to the report published on September 01st, 2023.
PIII Trading at -2.39% from the 50-Day Moving Average
After a stumble in the market that brought PIII to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.17% of loss for the given period.
Volatility was left at 8.51%, however, over the last 30 days, the volatility rate increased by 9.08%, as shares sank -0.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.56% upper at present.
During the last 5 trading sessions, PIII fell by -7.78%, which changed the moving average for the period of 200-days by -63.59% in comparison to the 20-day moving average, which settled at $0.5960. In addition, P3 Health Partners Inc saw -60.75% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PIII starting from Chicago Pacific Founders UGP I, who purchase 90,000 shares at the price of $2.65 back on Sep 13 ’23. After this action, Chicago Pacific Founders UGP I now owns 50,025,442 shares of P3 Health Partners Inc, valued at $238,221 using the latest closing price.
Chicago Pacific Founders UGP I, the 10% Owner of P3 Health Partners Inc, purchase 90,000 shares at $2.63 during a trade that took place back on Sep 12 ’23, which means that Chicago Pacific Founders UGP I is holding 49,935,442 shares at $236,520 based on the most recent closing price.
Stock Fundamentals for PIII
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- -0.06 for the gross margin
The net margin for P3 Health Partners Inc stands at -0.05. The total capital return value is set at -0.32. Equity return is now at value -453.01, with -7.71 for asset returns.
Based on P3 Health Partners Inc (PIII), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at -0.4. The debt to equity ratio resting at 0.8. The interest coverage ratio of the stock is -25.22.
Currently, EBITDA for the company is -81.19 million with net debt to EBITDA at -0.79. When we switch over and look at the enterprise to sales, we see a ratio of 0.19. The receivables turnover for the company is 9.03for trailing twelve months and the total asset turnover is 1.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.69.
Conclusion
In conclusion, P3 Health Partners Inc (PIII) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
